Skip to main content

Table 3 Association between vaccination and orchitis in males, by age group, Czech Republic, 2007–2012

From: Protective effect of vaccination against mumps complications, Czech Republic, 2007–2012

Age group

MUMPS in malesa number of cases

ORCHITIS - number (% of age group) of cases in males

ORCHITIS - number (%) of cases by number of doses

Odds ratiob (95 % CI)

Vaccine effectivenessb % (95 % CI)

   

0 doses

1 dose

2 doses

1 dose

2 doses

1 dose

2 doses

0

9

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

    

1–4

140

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

    

5–9

670

4 (0.6 %)

0 (0.0 %)

0 (0.0 %)

4 (100.0 %)

    

10–14

1161

30 (2.6 %)

2 (6.7 %)

0 (0.0 %)

28 (93.3 %)

 

0.19 (0.04, 0.87)

 

81 (13, 96)

15–19

2088

219 (10.5 %)

10 (4.6 %)

1 (0.5 %)

208 (95.0 %)

0.38 (0.04, 3.61)

0.26 (0.12, 0.55)

62 (-261, 96)

74 (45, 88)

20–24

690

129 (18.7 %)

50 (38.8 %)

1 (0.8 %)

78 (60.5 %)

0.49 (0.06, 4.28)

0.44 (0.29, 0.66)

51 (-328, 94)

56 (34, 71)

25–34

608

232 (38.2 %)

216 (93.1 %)

1 (0.4 %)

15 (6.5 %)

0.49 (0.05, 4.75)

0.40 (0.22, 0.73)

51 (-375, 95)

60 (27, 78)

35–44

117

31 (26.5 %)

31 (100.0 %)

0 (0.0 %)

0 (0.0 %)

    

45–54

68

11 (16.2 %)

11 (100.0 %)

0 (0.0 %)

0 (0.0 %)

    

55–64

30

1 (3.3 %)

1 (100.0 %)

0 (0.0 %)

0 (0.0 %)

    

65+

6

1 (16.7 %)

1 (100.0 %)

0 (0.0 %)

0 (0.0 %)

    

Total

5587

658 (11.8 %)

322 (48.9 %)

3 (0.5 %)

333 (50.6 %)

0.21 (0.06, 0.70)

0.17 (0.14, 0.20)

79 (30, 94)

83 (80, 86)

  1. Note
  2. a13 male three-dose vaccine recipients were not included in this analysis
  3. breference category is 0 doses